Publication date: Sep 22, 2023
To evaluate the primary health care (PHC) attributes and associated factors during the COVID-19 pandemic using the perspective of users. This cross-sectional, quantitative study included 422 PHC users from 96 Family Health Teams in a city in Brazil. The assessment used the Primary Care Assessment Tool (PCATool) and a structured questionnaire on the sociodemographic and epidemiological characteristics of users and basic health units (BHU). The Person’s chi-square test was used to analyze the association between high overall scores in PCATool and characteristics of users and BHU. Crude and adjusted prevalence ratios (PR) with a 95% confidence interval were also calculated. Poisson regression and Rao Scott’s Chi-square test were used to estimate crude PR. Most users were aged 30 to 39 years (26. 3%), women (75. 4%), registered at the BHU for over ten years (59. 5%), and had incomplete secondary education (30. 6%). The mean of PHC essential attributes and overall scores were low (6. 10 +/- 0. 81 and 5. 78 +/- 0. 77, respectively). “First-contact care-use” received the highest score (9. 22 +/- 1. 62), while “first-contact care-accessibility” received the lowest (2. 82 +/- 0. 90). High overall scores were associated with an average employment time of professionals (doctors and nurses) at the BHU (PR = 1. 31; 95% CI 1. 17-1. 48; p < 0. 001) and lower educational level of users (PR = 1. 71; 95% CI 1. 54-1. 90; p < 0. 001. "First-contact care-use" was the best evaluated, while "first-contact care-accessibility" was the worst. High scores were associated with a lower educational level of users and BHU with more experienced professionals.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Brazil | Assessment |
| Education | Attributes |
| Nurses | Bhu |
| Pandemic | Care |
| Years | Contact |
| Covid | |
| Cross | |
| High | |
| Pandemic | |
| Pcatool | |
| Phc | |
| Pr | |
| Primary | |
| Scores | |
| Sectional |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 pandemic |
| disease | MESH | Family Health |
| drug | DRUGBANK | Pentaerythritol tetranitrate |
| disease | VO | time |
| disease | MESH | educational level |
| drug | DRUGBANK | Ribostamycin |
| drug | DRUGBANK | Coenzyme M |
| drug | DRUGBANK | Pidolic Acid |
| drug | DRUGBANK | Ilex paraguariensis leaf |
| disease | IDO | history |
| disease | IDO | process |
| pathway | REACTOME | Reproduction |
| disease | VO | organization |
| disease | MESH | emergency |
| disease | IDO | country |
| disease | MESH | infection |
| disease | VO | protocol |
| disease | VO | population |
| drug | DRUGBANK | Trestolone |
| disease | VO | Equity |
| disease | VO | effectiveness |
| drug | DRUGBANK | Nonoxynol-9 |
| disease | VO | vaccinated |
| disease | VO | vaccination |
| disease | MESH | chronic disease |
| drug | DRUGBANK | L-Valine |
| drug | DRUGBANK | Aspartame |
| disease | VO | frequency |
| disease | MESH | Hypertension |
| disease | MESH | Obesity |
| disease | VO | effective |
| disease | MESH | infectious diseases |
| disease | VO | efficient |
| disease | VO | efficiency |
| drug | DRUGBANK | Serine |
| drug | DRUGBANK | Mitomycin |
| disease | MESH | Primary Care Accessibility |